Zhejiang Tianyu Pharmaceutical Co Ltd Net Asset Quality Index
Zhejiang Tianyu Pharmaceutical Co Ltd net asset quality index. Zhejiang Tianyu Pharmaceutical Co Ltd (300702) has a Net Asset Quality Index of 52.3% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥6.89 Billion minus total liabilities of CN¥3.28 Billion yields net assets of CN¥3.61 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 300702 net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Zhejiang Tianyu Pharmaceutical Co Ltd (2013–2025)
Net asset quality index of Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025. This chart shows how Zhejiang Tianyu Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 52.3%, representing net assets of CN¥3.61 Billion against total assets of CN¥6.89 Billion CNY. Check Zhejiang Tianyu Pharmaceutical Co Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Zhejiang Tianyu Pharmaceutical Co Ltd Net Asset Quality Index by Year (2013–2025)
Zhejiang Tianyu Pharmaceutical Co Ltd net asset quality index by year from 2013 to 2025. The table below presents the year-by-year Net Asset Quality Index for Zhejiang Tianyu Pharmaceutical Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 300702 stock market capitalisation.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 55.2% | CN¥3.64 Billion | CN¥6.59 Billion | CN¥2.95 Billion | ▲ +2.1 pp |
| 2024 | 53.2% | CN¥3.50 Billion | CN¥6.58 Billion | CN¥3.08 Billion | ▼ -1.9 pp |
| 2023 | 55.0% | CN¥3.49 Billion | CN¥6.34 Billion | CN¥2.85 Billion | ▲ +0.6 pp |
| 2022 | 54.5% | CN¥3.50 Billion | CN¥6.42 Billion | CN¥2.92 Billion | ▼ -9.5 pp |
| 2021 | 63.9% | CN¥3.71 Billion | CN¥5.80 Billion | CN¥2.09 Billion | ▼ -8.6 pp |
| 2020 | 72.5% | CN¥3.55 Billion | CN¥4.89 Billion | CN¥1.34 Billion | ▲ +0.8 pp |
| 2019 | 71.7% | CN¥2.04 Billion | CN¥2.84 Billion | CN¥803.09 Million | ▲ +16.7 pp |
| 2018 | 55.0% | CN¥1.45 Billion | CN¥2.63 Billion | CN¥1.18 Billion | ▼ -6.1 pp |
| 2017 | 61.1% | CN¥1.29 Billion | CN¥2.11 Billion | CN¥818.99 Million | ▲ +21.0 pp |
| 2016 | 40.1% | CN¥607.31 Million | CN¥1.52 Billion | CN¥907.72 Million | ▲ +2.7 pp |
| 2015 | 37.4% | CN¥495.77 Million | CN¥1.33 Billion | CN¥830.58 Million | ▼ -4.7 pp |
| 2014 | 42.1% | CN¥456.22 Million | CN¥1.08 Billion | CN¥628.67 Million | ▼ -4.6 pp |
| 2013 | 46.7% | CN¥453.68 Million | CN¥971.79 Million | CN¥518.11 Million | — |